Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cancer Res. 2015 Nov 20;76(3):664–674. doi: 10.1158/0008-5472.CAN-15-0828

Figure 4. Synergistic MR drive t-DLBCL cell proliferation and define transformed FL gene signature.

Figure 4

(A) Cell viability measured by PrestoBlue at 24h after single and paired MRs silencing of in SUDHL6, SUDHL4, HF1 and CB33 cell lines. (B) GSEA of differentially expressed genes after MR silencing in SUDHL6 cell line in patient-derived signatures of FL transformation.